Dacogen decitabine: Preliminary Phase II data

Preliminary data from 99 patients in an open-label Phase II trial showed that 20 mg/m 2 of IV Dacogen produced a complete response rate of 32%. Median survival was 19.4 months and the 1-year survival ...